The global regenerative medicine products market is expected to grow at a CAGR of 12.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising geriatric population, and growing demand for minimally invasive surgeries.
Cell therapy segment accounted for the largest share in the global regenerative medicine products market in 2018 and is expected to continue its dominance throughout the forecast period. Cell therapy segment includes cell-based therapies such as stem cells and mesenchymal stem cells (MSCs). Cell-based therapies are used in various applications such as dermatology, cardiovascular, CNS, orthopedic and others. Dermatology application accounted for the largest share in cell-based therapies segment due to increasing prevalence of skin disorders like psoriasis and vitiligo globally. Cardiovascular application accounted for second largest share due to high incidence of heart diseases globally which can be treated with cell-based therapies like MSCs that have been shown to improve cardiac function after myocardial infarction or heart failure. CNS application accounted for third largest share due to high incidence of neurological disorders globally which can be treated with cell-based therapies like neural progenitor cells (NPCs) that have been shown to improve cognitive function after stroke or spinal cord injury among others. Orthopedic application accounted for fourth largest share due to high incidence of musculoskeletal disorders globally which can be treated with bone marrow derived mesenchymal stem cells (BMMSCs) that have been shown increase bone formation among other benefits following joint replacement surgery or fracture repair surgery among others.
- The regenerative medicine products market is expected to grow at a CAGR of 12.5% from 2017 to 2025, owing to the increasing demand for minimally invasive procedures and the rising incidence of chronic diseases.
- Regenerative medicine products are used in various medical fields such as orthopedics, neurology, cardiology, oncology and others.
- Regenerative Medicine Products Market Growth Factors: Increasing prevalence of chronic diseases; growing demand for minimally invasive procedures.
Industry Growth Insights published a new data on “Regenerative Medicine Products Market”. The research report is titled “Regenerative Medicine Products Market research by Types (Cell Therapy, Tissue Engineering, Biomaterial, Others), By Applications (Dermatology, Cardiovascular, CNS, Orthopedic, Others), By Players/Companies Acelity, DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori Therapeutics, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologes, Bellicum Pharmaceuticals”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Regenerative Medicine Products Market Research Report
By Type
Cell Therapy, Tissue Engineering, Biomaterial, Others
By Application
Dermatology, Cardiovascular, CNS, Orthopedic, Others
By Companies
Acelity, DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori Therapeutics, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologes, Bellicum Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
246
Number of Tables & Figures
173
Customization Available
Yes, the report can be customized as per your need.
Global Regenerative Medicine Products Market Report Segments:
The global Regenerative Medicine Products market is segmented on the basis of:
Types
Cell Therapy, Tissue Engineering, Biomaterial, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Dermatology, Cardiovascular, CNS, Orthopedic, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Acelity
- DePuy Synthes
- Medtronic
- ZimmerBiomet
- Stryker
- MiMedx Group
- Organogenesis
- UniQure
- Cellular Dynamics International
- Osiris Therapeutics
- Vcanbio
- Gamida Cell
- Golden Meditech
- Cytori Therapeutics
- Celgene
- Vericel Corporation
- Guanhao Biotech
- Mesoblast
- Stemcell Technologes
- Bellicum Pharmaceuticals
Highlights of The Regenerative Medicine Products Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Cell Therapy
- Tissue Engineering
- Biomaterial
- Others
- By Application:
- Dermatology
- Cardiovascular
- CNS
- Orthopedic
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Regenerative Medicine Products Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Regenerative medicine products are medical devices and treatments that help regenerate tissue.
Some of the key players operating in the regenerative medicine products market are Acelity, DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, Osiris Therapeutics, Vcanbio, Gamida Cell, Golden Meditech, Cytori Therapeutics, Celgene, Vericel Corporation, Guanhao Biotech, Mesoblast, Stemcell Technologes, Bellicum Pharmaceuticals.
The regenerative medicine products market is expected to grow at a compound annual growth rate of 12.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Regenerative Medicine Products Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Regenerative Medicine Products Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Regenerative Medicine Products Market - Supply Chain
4.5. Global Regenerative Medicine Products Market Forecast
4.5.1. Regenerative Medicine Products Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Regenerative Medicine Products Market Size (000 Units) and Y-o-Y Growth
4.5.3. Regenerative Medicine Products Market Absolute $ Opportunity
5. Global Regenerative Medicine Products Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Regenerative Medicine Products Market Size and Volume Forecast by Type
5.3.1. Cell Therapy
5.3.2. Tissue Engineering
5.3.3. Biomaterial
5.3.4. Others
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Regenerative Medicine Products Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Regenerative Medicine Products Market Size and Volume Forecast by Application
6.3.1. Dermatology
6.3.2. Cardiovascular
6.3.3. CNS
6.3.4. Orthopedic
6.3.5. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Regenerative Medicine Products Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Regenerative Medicine Products Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Regenerative Medicine Products Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Regenerative Medicine Products Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Regenerative Medicine Products Demand Share Forecast, 2019-2026
9. North America Regenerative Medicine Products Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Regenerative Medicine Products Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Regenerative Medicine Products Market Size and Volume Forecast by Application
9.4.1. Dermatology
9.4.2. Cardiovascular
9.4.3. CNS
9.4.4. Orthopedic
9.4.5. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Regenerative Medicine Products Market Size and Volume Forecast by Type
9.7.1. Cell Therapy
9.7.2. Tissue Engineering
9.7.3. Biomaterial
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Regenerative Medicine Products Demand Share Forecast, 2019-2026
10. Latin America Regenerative Medicine Products Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Regenerative Medicine Products Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Regenerative Medicine Products Market Size and Volume Forecast by Application
10.4.1. Dermatology
10.4.2. Cardiovascular
10.4.3. CNS
10.4.4. Orthopedic
10.4.5. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Regenerative Medicine Products Market Size and Volume Forecast by Type
10.7.1. Cell Therapy
10.7.2. Tissue Engineering
10.7.3. Biomaterial
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Regenerative Medicine Products Demand Share Forecast, 2019-2026
11. Europe Regenerative Medicine Products Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Regenerative Medicine Products Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Regenerative Medicine Products Market Size and Volume Forecast by Application
11.4.1. Dermatology
11.4.2. Cardiovascular
11.4.3. CNS
11.4.4. Orthopedic
11.4.5. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Regenerative Medicine Products Market Size and Volume Forecast by Type
11.7.1. Cell Therapy
11.7.2. Tissue Engineering
11.7.3. Biomaterial
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Regenerative Medicine Products Demand Share, 2019-2026
12. Asia Pacific Regenerative Medicine Products Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Regenerative Medicine Products Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Regenerative Medicine Products Market Size and Volume Forecast by Application
12.4.1. Dermatology
12.4.2. Cardiovascular
12.4.3. CNS
12.4.4. Orthopedic
12.4.5. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Regenerative Medicine Products Market Size and Volume Forecast by Type
12.7.1. Cell Therapy
12.7.2. Tissue Engineering
12.7.3. Biomaterial
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Regenerative Medicine Products Demand Share, 2019-2026
13. Middle East & Africa Regenerative Medicine Products Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Regenerative Medicine Products Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Regenerative Medicine Products Market Size and Volume Forecast by Application
13.4.1. Dermatology
13.4.2. Cardiovascular
13.4.3. CNS
13.4.4. Orthopedic
13.4.5. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Regenerative Medicine Products Market Size and Volume Forecast by Type
13.7.1. Cell Therapy
13.7.2. Tissue Engineering
13.7.3. Biomaterial
13.7.4. Others
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Regenerative Medicine Products Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Regenerative Medicine Products Market: Market Share Analysis
14.2. Regenerative Medicine Products Distributors and Customers
14.3. Regenerative Medicine Products Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Acelity
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. DePuy Synthes
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Medtronic
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ZimmerBiomet
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Stryker
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. MiMedx Group
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Organogenesis
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. UniQure
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Cellular Dynamics International
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Osiris Therapeutics
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Vcanbio
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Gamida Cell
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Golden Meditech
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Cytori Therapeutics
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Celgene
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. Vericel Corporation
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Guanhao Biotech
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Mesoblast
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Stemcell Technologes
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Bellicum Pharmaceuticals
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
